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The renal action of atrial natriuretic peptide during control of
glomerular filtration
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The renal action of atrial natriuretic peptide during control of glomer-
ular filtration. Studies were performed in anesthetized dogs (N = 7) to
determine the effects of synthetic atrial natriuretic peptide (ANP) on
sodium excretion in the presence and absence of control of glomerular
filtration rate produced by suprarenal aortic clamping. Intrarenal infu-
sion of synthetic atrial natriuretic peptide (0.3 g/kg/min) significantly
increased glomerular filtration rate from 29.3 3.0 to 43.2 4.4
ml/min, urinary sodium excretion from 20.1 10.3 to 223.3 52.3
sEq/min, fractional sodium excretion from 0.47 0.19 to 3.75
0.59%. In contrast, aortic clamping blocked the incrcase in glomerular
filtration rate in association with an attenuated natriuresis. Urinary
sodium excretion increased from 6.3 2.3 to 68.3 23.4 jzEq/min and
fractional sodium excretion increased from 0.15 0.04 to 0.90
0.30%. Despite this differential response in glomerular filtration rate and
sodium excretion, whole kidney fractional delivery of sodium from the
proximal tubule as estimated by the fractional excretion of lithium
increased during both unclamped (17.7 1.8 to 30.4 0.8%) and
clamped (12.9 2.1 to 23.9 2.7%) periods. These studies demon-
strate that atrial natriuretic peptide—induced natriuresis is importantly
mediated by an increase in glomerular filtration rate and decrease in
tubular reabsorption.
Recent investigations employing both crude atrial extract and
newly available synthetic atrial natriuretic peptide have repeat-
edly demonstrated that the natriuretic response to this peptide
is associated with an increase in glomerular filtration rate 1—3].
While some investigations have suggested an effect of atrial
peptides on tubular reabsorption [1, 4, 16], most studies support
the hypothesis that atrial natriuretic peptide—induced natriure-
sis is mediated by an enhancement of the filtration process
1—3]. No studies have been performed, however, to establish
the dependency of atrial natriuretic peptide—induced natriuresis
on glomerular filtration rate in the normally functioning kidney
employing a specific synthetic atrial natriuretic peptide frag-
ment.
The present study was therefore designed to elucidate the
contribution of glomerular filtration rate in the mechanism of
atrial natriuretic peptide—induced natriuresis. Aortic clamping
was used to block the predicted increase in glomerular filtration
rate during administration of synthetic atrial natriuretic peptide
in anesthetized dogs. This experimental maneuver has been
employed in previous investigations which established the role
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of glomerular filtration rate in the natriuretic response to the
peptide glucagon [6, 7].
Methods
Experiments were performed on seven mongrel dogs of either
sex (16 to 22 kg body wt). The dogs were fasted overnight prior
to the acute experiment but allowed access to water. Dogs were
anesthetized with sodium pentobarbital (30 mg/kg) and main-
tained with supplemental doses as necessary. The trachea was
intubated with a cuffed endotracheal tube and the dogs were
ventilated with a Harvard Apparatus respirator. A femoral vein
was cannulated for infusions and obtaining blood samples. Two
catheters were inserted via the femoral artery and placed below
and above the aortic clamp to assess systemic blood pressure
and renal perfusion pressure. The left kidney and left renal
artery were isolated via a retroperitoneal flank incision. The
dogs were supported in a metal frame that held them in a
position approximating their normal upright posture. A noncan-
nulating flow probe (Carolina Medical Electronics, King, North
Carolina, USA) was placed around the left renal artery and a
small needle was inserted into the artery distal to the flow
probe. The left ureter was cannulated for collection of urine
from the left kidney only. An infusion of saline (1 mI/mm) was
initiated to maintain the patency of the needle. A
variable—resistance Blalock clamp was placed around the aorta
just proximal to the renal arteries without causing any constric-
tion.
After the surgical preparation, an inulin infusion was begun in
the femoral vein at I mi/mm at a concentration calculated to
produce a plasma concentration of 50 mg/dl. At the end of this
equilibration period, two 15 mm clearances were performed,
with a blood sample obtained either in the middle of a single
clearance or between the two clearances. I'he saline infusion
into the renal artery was then replaced by an infusion of
synthetic ANP (8-33, Peninsula Lab., Belmont, California,
USA) at a rate of 0.3 g . kg1 . min for a total of 45 mm.
Fifteen mm after initiation of synthetic ANP infusion, two 15
mm clearances were obtained. The infusion was stopped.
Following a 45 mm washout period, two 15 mm recovery
clearances were obtained. After the recovery clearance, the
clamp was tightened to decrease renal blood flow to the lowest
level of renal blood flow autoregulation determined by that
pressure at which renal blood flow began to fall. Following a 30
mm equilibration period, the above protocol was repeated. In
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four of the seven dogs, the clamping protocol preceded the
unclamped protocol.
Glomerular filtration rate was measured hy the clearance of
inulin. Inulin concentrations were measured by the anthrone
method [8]. Concentrations of sodium and potassium were
measured using ion-selective electrodes (Beckman E2A ana-
lyzer, Beckman Instruments, Fullerton, California, USA).
Whole kidney proximal tubular reabsorption of sodium was
estimated by the lithium—clearance technique. This technique
has been shown to be a reliable method for estimating delivery
of sodium from the proximal tubule, since lithium is reabsorbed
exclusively by the proximal tubule [9, 10]. This method is based
on evidence indicating that lithium is rcabsorbed almost exclu-
sively in the proximal tubule, including the pars recta, in
parallel with sodium and water. Micropuncture studies have
shown that fractional lithium reabsorption correlates very well
with proximal sodium reabsorption over a wide range of prox-
imal reabsorption rates. In addition, diuretics that predomi-
nantly inhibit sodium transport in the ascending limb of the loop
of Henle and the distal tubule and collecting duct do not
increase urinary lithium excretion [5]. In contrast, maneuvers
known to inhibit proximal sodium reabsorption, such as
acetazolamide and osmotic diuretics, increase lithium excretion
[11]. The dogs were given 300 mg of lithium (orally) the night
before each experiment. Lithium concentration in plasma and
urine was measured by flame emission spectrophotometry
(model 357, Instrumentation Laboratory, Lexington, Massa-
chusetts, USA).
All data from the two clearances at baseline, atrial natriuretic
peptide, and recovery periods were averaged and arc expressed
as means 5E. The data were analyzed using Dunnett's paired
t-test for simultaneous multiple comparisons.
Results
Table 1 and Figure 1 summarize the renal hemodynamic and
excretory response data during control, intrarenal infusion of
synthetic atrial natriuretic pcptidc, and recovery for seven dogs
in the presence and absence of control of glomerular filtration
rate.
In the absence of suprarcnal aortic constriction, intrarenal
ANP infusion resulted in a significant increase in glomerular
filtration rate (29.3 3.0 to 43,2 4.4 mI/mm, P <0.02), urine
flow (0.37 0.17 to 2.46 0.68 mI/mm, P < 0.05), urinary
sodium excretion (20.1 10.3 to 223.3 52.3 jzEq/min, P <
0.005), fractional sodium excretion (0.47 0.17 to 3.75
0.59%, P <0.005), and fractional lithium excretion (17.7 1.8
to 30.4 0.8%, P < 0.005). Although renal blood flow did not
significantly change (168 21 to 175 23 mi/mm), renal
vascular resistance decreased (0.76 t 0.06 to 0.68 0.06 mm
Hg (ml mm) , P < 0.05) in association with a decrease in
mean arterial pressure (119 3 to 109 3 mm Hg, P <0.05).
Urine osmolality decreased from 932 265 to 383 58
mOsmol/kg H20 (P < 0.05). Filtration fraction increased from
0.33 0.05 to 0.46 0.06, P < 0.02.
During aortic clamping, glomerular filtration rate did not
significantly increase from 27.4 1.9 mI/mm. Despite the
absence of a significant increase in glomerular filtration rate
during ANP infusion, whole kidney proximal tubular delivery of
sodium as estimated from the clearance of lithium increased.
Fractional lithium excretion increased from 12.9 2.1 to 23.9
Table 1. Renal hemodynamic and excretory responses to intrarenal
infusion of synthetic atrial natriuretic peptide in the presence and
absence of control of glomerular filtration rate (N = 7)
Unelamped
AN F
Baseline (0.3 j.cglkg/min) Recovery
MAP,mmHg 119±3 109±3* 112±3*
RBF, ml/min 168 21 175 23 159 18
GFR, mI/mm 29.3 3.0 43.2 44** 30.6 3.3
RVR,
mm Hg ' (ml/mmn1 0.76 0.06 0.68 0.06* 0.73 0.05
FF 0.33 0.05 0.46 0.06 0.35 0.03
V, ml/min 0.37 0.17 2.46 0.68* 0.44 0.14
Uosmoi, mOsmol/kg H20 932 265 383 58* 702 155
UNV, p.Eq/min 20.1 10.3 223.3 52.3*** 51.9 12.9**
FENa, % 0.47 0.17 3.75 0.59*** 1.31 0.62
FEL, % 17.7 1.8 30.4 0.8*** 22.5 14.4*
Clamped
Baseline
ANF
(0.3 gg/kg/min) Recovery
MAP,mmHg 128±8 121 7* 128±5
RBF, mI/mitt 182 21 173 19 149 14**
GFR, ml/mmn 27.4 1.9 28.0 1.5 31.2 4.0
RVR,
mm Hg' (ml/minf'1 0.79 0.11 0.79 0.11 0.93 0.l1**
FF 0.27 0.04 0.33 0.04* 0.39 0.07
V, mI/mitt 0.18 0.06 0.56 0.16* 0.24 0.38
U051, mosmllkg 1120 841 194 665 137 742 148
UNV, jzEq/min 6.3 2.3 68.3 23.4* 12.3 4.0
FENa, % 0.15 0.04 0.90 0.30* 0.31 0.11
FE1, % 12.9 2.1 23.9 2.7** 16.7 2.6**
Values are means 5E. Ahbreviations are: MAP, mean arterial
pressure; RBF, renal blood flow; GFR, glomerular filtration rate; RVR,
renal vascular resistance; FF, filtration fraction; V, urine flow; Uosnioj,
urinary osmolality; UNaV, urinary sodium excretion; FENa, fractional
excretion of sodium; FEL, fractional excretion of lithium. P values
compare results with baseline: * P C 0.05; ** P C 0.02, P C 0.005.
2.7%, P <0.02. Increases were observed in urine flow from
0.18 0.06 to 0.56 0.16 mI/mm (P < 0.05), urinary sodium
excretion from 6.3 2.3 to 68.3 23.4 ,aEq/min, P <0.05, and
fractional excretion of sodium from 0.15 0.04 to 0.90
0.30%. Urine osmolality was unchanged at 841 194
mOsmol/kg H20. Renal blood flow and renal vascular resist-
ance also did not change. Filtration fraction, however, in-
creased (0.27 0.04 to 0.33 0.04, P < 0.05), and mean
arterial pressure decreased (128 8 to 121 7 mm Hg, P C
0.05).
Discussion
Intrarenal infusion of synthetic atrial natriuretic peptide
resulted in a marked increase in sodium excretion in the
absence of aortic clamping. This marked natriuretic response
was associated with a significant increase in glomerular filtra-
tion rate. Aortie clamping prevented the predicted increase in
glomerular filtration rate and attenuated the natriuretic re-
sponse to atrial natriuretic peptide. Although the natriuretie
response to atrial natriuretic peptide was attenuated by clamp-
ing, this attenuated natriuresis occurred in association with a
decrease in whole kidney proximal tubule reabsorption, as
estimated by the clearance of lithium. Thus, the present study
confirms an important relationship between atrial natriuretic
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peptide—induced natriuresis and glomerular filtration rate, but
establishes a natriuretic response independent from increases in
the filtration process.
Recent studies have reported an important relationship be-
tween atrial natriuretic peptide natriuresis and glomerular fil-
tration rate. In the isolated perfused kidney preparation, intra-
renal infusion of crude atrial extract resulted in a significant
increase in both glomerular filtration rate and sodium excretion
[12]. Beasley and Malvin extended earlier studies and reported
that continuous infusion of crude atrial extract in rats resulted
in significant increases in both glomerular filtration rate and
sodium excretion, in contrast to ventricular extracts which
failed to augment glomerular filtration rate or sodium excretion
[3]. Recent purification, sequencing, and synthesis of atrial
natriuretic factor have resulted in the availability of synthetic
peptide fragments with pure biological activity. Synthetic atrial
peptides have permitted further elucidation of the precise action
of this peptide system on renal function, Several studies have
now consistently demonstrated an important association be-
tween urinary sodium excretion and glomerular filtration rate
during infusion of synthetic atrial peptide fragments [1, 2, 13].
The present studies importantly extend previous studies em-
ploying synthetic atrial natriuretic peptide, and establish an
important relationship between atrial natriuretic peptide—
induced natriuresis and glomerular filtration rate.
The mechanism by which atrial natriuretic peptide increases
glomerular filtration rate remains to be defined. Based on the
significant increase in filtration fraction with no significant
increase in renal blood flow, we reported in previous studies
that the increase in glomerular filtration rate may be mediated
by a balanced action on segmental renal vascular resistances, in
which preglomerular resistance is decreased and postglomeru-
lar resistance increased [1]. Preliminary micropuncture studies
in the rat by Ichikawa et al are in agreement with such an
interpretation [14]. A separate mechanism may involve a direct
action of atrial natriuretic peptide to increase the coefficient for
ultrafiltration, Kf, recognizing the demonstration of atrial natri-
uretic peptide—induced generation of cGMP within the
glomerulus [15].
The present studies are similar to previous investigations
which employed aortic clamping to define the mechanism of
glucagon—induced natriuresis [6, 7]. Such previous studies
definitively demonstrated by the maneuver used in the present
study that the natriuretic response to the peptide glucagon is
dependent on an increase in glomerular filtration rate with no
evidence for a tubular effect. In contrast to the glucagon
studies, the present studies demonstrate that despite the aboli-
tion of atrial natriuretic peptide—induced increase in glomerular
filtration rate, a proximal tubular action of atrial natriuretic
peptide as estimated by the clearance of lithium may contribute
to the attenuated natriuresis. The fractional delivery of sodium
from the proximal tubule as estimated by the increase in
fractional lithium excretion occurred in both the presence and
absence of control of glomerular filtration rate. The decrease in
whole kidney proximal tubule reabsorption, despite a blunted
increase in glomerular filtration rate during aortic clamping,
would support the conclusion that the decrease in proximal
tubule reabsorption of superficial and/or deep nephrons in
response to synthetic atrial natriuretic peptide is not dependent
on an increased filtered load of this ion. Such a conclusion is
supported by the recent report from Hammond and colleagues
that sodium co-transport is inhibited in proximal tubular brush
border vesicles harvested from rats undergoing atrial natriuretic
peptide—induced natriuresis [161. The present studies demon-
strate a dissociation between glomerular filtration rate and
whole kidney proximal tubule reabsorption as estimated by the
clearance of lithium, such that whole kidney proximal tubule
reabsorption decreases in response to atrial natriuretic peptide
during aortic clamping, despite the absence of an increase in the
filtration process. Thus, the present findings support the con-
clusion of a proximal tubular action of atrial natriuretic peptide.
Aortic clamping blocked the decrease in urinary osmolality as
well as the increase in glomerular filtration rate, suggesting
another contributing mechanism to the attenuated natriuretic
response to atrial natriuretic peptide during control of glomer-
ular filtration rate. Previous studies have suggested that med-
ullary washout, due to increased papillary plasma flow charac-
teristic of renal vasodilators, may occur during ANP infusion
[171. The present studies suggest that aortic clamping may
prevent medullary washout, and that without decreases in the
medullary gradient, the natriuretic response to atrial natriuretic
peptide is prevented [1, 2, 17].
In summary, the present findings suggest that reduction in
renal artery perfusion pressure to the lowest levels of renal
blood flow autoregulation prevents atrial natriuretic
peptide—induced increases in glomerular filtration rate, and
attenuate the subsequent natriuresis supporting a role for
glomerular filtration rate in the natriuretic response to this
peptide hormone. The observation, however, of a natriuretic
response and increase in fractional excretion of lithium during
aortic clamping, despite the absence of an increase in glomer-
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Fig. 1. The effect of atrial natriuretic peptide (ANP) on renal function in
the presence and absence of control of glomerularfiliration rate (GFR).
Symbols are: (0) absence of control of GFR; (•) control of GFR.
Abbreviations are: FELl, fractional excretion of lithium; UNaV, urinary
sodium excretion; FENa, fractional excretion of sodium (N 7).
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ular filtration rate, supports a direct or indirect action of atrial
natriuretic peptide on proximal tubular reabsorption.
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